InspireMD, Inc.
NASDAQ:NSPR
2.37 (USD) • At close July 30, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 7.009 | 6.205 | 5.171 | 4.495 | 2.485 | 3.721 | 3.601 | 2.761 | 1.894 | 2.31 | 2.818 | 4.873 | 5.349 | 6.004 | 0 | 3.411 |
| Cost of Revenue
| 5.503 | 4.398 | 4.054 | 3.741 | 2.402 | 2.965 | 2.606 | 2.176 | 1.792 | 2.606 | 2.034 | 2.283 | 2.849 | 3.011 | 0 | 0 |
| Gross Profit
| 1.506 | 1.807 | 1.117 | 0.754 | 0.083 | 0.756 | 0.995 | 0.585 | 0.102 | -0.296 | 0.784 | 2.59 | 2.5 | 2.993 | 0 | 0 |
| Gross Profit Ratio
| 0.215 | 0.291 | 0.216 | 0.168 | 0.033 | 0.203 | 0.276 | 0.212 | 0.054 | -0.128 | 0.278 | 0.532 | 0.467 | 0.499 | 0 | 0 |
| Reseach & Development Expenses
| 13.634 | 7.981 | 7.81 | 5.158 | 2.233 | 2.954 | 1.535 | 1.276 | 1.291 | 3.642 | 8.744 | 4.156 | 3.988 | 2.474 | 0 | 0 |
| General & Administrative Expenses
| 15.306 | 11.104 | 8.356 | 7.405 | 6.127 | 5.222 | 4.83 | 5.184 | 5 | 6.387 | 9.125 | 8.973 | 13.883 | 12.275 | 0.015 | 0.004 |
| Selling & Marketing Expenses
| 6.069 | 3.865 | 3.664 | 2.907 | 2.103 | 2.396 | 2.241 | 2.357 | 1.459 | 3.178 | 6.613 | 3.616 | 2.174 | 1.973 | 0 | 0 |
| SG&A
| 21.375 | 14.969 | 12.02 | 10.312 | 8.23 | 7.618 | 7.071 | 7.541 | 6.459 | 9.565 | 15.738 | 12.589 | 16.057 | 14.248 | 0.015 | 0.004 |
| Other Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.918 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 35.009 | 22.95 | 19.83 | 15.47 | 10.463 | 10.572 | 8.606 | 8.817 | 7.75 | 13.207 | 24.482 | 17.663 | 20.045 | 16.722 | 0.015 | 0.004 |
| Operating Income
| -33.503 | -21.143 | -18.713 | -14.716 | -10.38 | -9.816 | -7.611 | -8.232 | -7.648 | -14.485 | -23.698 | -15.073 | -17.545 | -13.729 | -0.015 | -0.004 |
| Operating Income Ratio
| -4.78 | -3.407 | -3.619 | -3.274 | -4.177 | -2.638 | -2.114 | -2.982 | -4.038 | -6.271 | -8.41 | -3.093 | -3.28 | -2.287 | 0 | -0.001 |
| Total Other Income Expenses Net
| 1.557 | 1.292 | 0.25 | -0.157 | -0.16 | -0.2 | 0.371 | -0.179 | -0.812 | -1.096 | -1.385 | -14.177 | -0.038 | -0.934 | -0.154 | 0.04 |
| Income Before Tax
| -31.946 | -19.851 | -18.463 | -14.873 | -10.54 | -10.016 | -7.24 | -8.411 | -8.46 | -15.581 | -25.083 | -29.25 | -17.583 | -14.663 | -3.373 | -2.677 |
| Income Before Tax Ratio
| -4.558 | -3.199 | -3.57 | -3.309 | -4.241 | -2.692 | -2.011 | -3.046 | -4.467 | -6.745 | -8.901 | -6.002 | -3.287 | -2.442 | 0 | -0.785 |
| Income Tax Expense
| 0.059 | 0.065 | 0.028 | 0.045 | 0.004 | 0.024 | 0 | 0.027 | 0.001 | 0.004 | 0.012 | 0.008 | 0.014 | 0.002 | 0.024 | 0.004 |
| Net Income
| -32.005 | -19.916 | -18.491 | -14.918 | -10.544 | -10.04 | -7.24 | -8.438 | -8.461 | -15.585 | -25.095 | -29.258 | -17.597 | -14.665 | -0.024 | -0.004 |
| Net Income Ratio
| -4.566 | -3.21 | -3.576 | -3.319 | -4.243 | -2.698 | -2.011 | -3.056 | -4.467 | -6.747 | -8.905 | -6.004 | -3.29 | -2.443 | 0 | -0.001 |
| EPS
| -0.76 | -0.82 | -2.35 | -2.03 | -6.97 | -72 | -247.5 | -4,265.93 | -151,089.29 | -1,416,818.18 | -4,182,500 | -5,851,600 | -9,217.92 | -7,332,500 | -3,425.14 | -956.25 |
| EPS Diluted
| -0.76 | -0.82 | -2.35 | -2.03 | -6.97 | -72 | -247.5 | -4,265.93 | -151,089.29 | -1,416,818.18 | -4,182,500 | -5,851,600 | -9,217.92 | -7,332,500 | -3,425.14 | -956.25 |
| EBITDA
| -33.223 | -20.911 | -18.525 | -14.555 | -10.229 | -9.658 | -7.459 | -8.114 | -7.548 | -14.244 | -23.411 | -14.865 | -16.225 | -13.342 | -3.177 | -2.367 |
| EBITDA Ratio
| -4.74 | -3.37 | -3.582 | -3.238 | -4.116 | -2.596 | -2.071 | -2.939 | -3.985 | -6.166 | -8.308 | -3.05 | -3.033 | -2.222 | 0 | -0.694 |